Grant: Project Grant
University of Manitoba
$848,595.00
Development of magnetic tumor killing nanoparticles to breakthrough the blood-brain barrier
FY 2015-16
Summary
Normal brain function requires a highly regulated and controlled environment. The brain capillaries that form the blood-brain barrier (BBB) have a special role in maintaining the proper brain environment. However, for many brain related diseases and disorders, the limited BBB permeability of drugs presents a substantial obstacle to effective treatment. This is certainly the case for glioblastomas, the most commonly occurring brain tumor in adults. Our project builds on our previous work establishing an approach for delivery of magnetic nanoparticles across the BBB. In the present study, we examine the use of magnetic nanoparticles as drug carriers to increase drug delivery to the brain and improve the treatment of brain tumors. The specific aims of this research project are to examine the influence of nanoparticle shape, and surface chemistry to hone in on the optimal magnetic nanoparticle composition for enhanced BBB penetration. Based on our previous studies, we believe non-spherical shaped nanoparticles will provide better BBB penetration and better magnetic targeting properties. These magnetic nanoparticles will be evaluated for delivery of drug and therapeutic response in a series of patient derived glioblastoma cells. Those nanoparticles with the best response in cell culture will be examined for effectiveness in an animal model of glioblastoma. In addition, the effects of the magnetic nanoparticles on normal cellular function in the brain will be examined. The ultimate goal of these studies is to provide a new method for the safe and effective treatment of brain tumors and potentially other brain related diseases.
Department
Program
Project Grant
Recipient
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
346221
Name
Miller Donald W
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Project Grant Competition
Projecttitle
Development of magnetic tumor killing nanoparticles to breakthrough the blood-brain barrier
Programtype2
Operating Grants
Orgnameinp2
University of Manitoba
Cihramount2
$848,595
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Blood-Brain Barrier; Brain Endothelial Cell; Brain Tumor; Chemotherapeutics; Drug Delivery; Glioblastoma; Hyperthermia; Magnetism; Nanoparticles; Neuroinflammation
Abstract
Normal brain function requires a highly regulated and controlled environment. The brain capillaries that form the blood-brain barrier (BBB) have a special role in maintaining the proper brain environment. However, for many brain related diseases and disorders, the limited BBB permeability of drugs presents a substantial obstacle to effective treatment. This is certainly the case for glioblastomas, the most commonly occurring brain tumor in adults. Our project builds on our previous work establishing an approach for delivery of magnetic nanoparticles across the BBB. In the present study, we examine the use of magnetic nanoparticles as drug carriers to increase drug delivery to the brain and improve the treatment of brain tumors. The specific aims of this research project are to examine the influence of nanoparticle shape, and surface chemistry to hone in on the optimal magnetic nanoparticle composition for enhanced BBB penetration. Based on our previous studies, we believe non-spherical shaped nanoparticles will provide better BBB penetration and better magnetic targeting properties. These magnetic nanoparticles will be evaluated for delivery of drug and therapeutic response in a series of patient derived glioblastoma cells. Those nanoparticles with the best response in cell culture will be examined for effectiveness in an animal model of glioblastoma. In addition, the effects of the magnetic nanoparticles on normal cellular function in the brain will be examined. The ultimate goal of these studies is to provide a new method for the safe and effective treatment of brain tumors and potentially other brain related diseases.
Competitiondate
201603
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Miller, Donald W; Klonisch, Thomas; van Lierop, Johan
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $848,595~ $0~